BCAT vs ODTX Comparison

BlackRock Capital Allocation Trust, now BlackRock Capital Allocation Term Trust, is a diversified, closed-end management investment company. Its investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. The Trust invests in a portfolio of both equity and debt securities of companies from different sectors such as Information Technology, Financials, Industrials, Communication, Health Care, etc. It also utilizes an option-writing (selling) plan in an effort to generate current gains from option premiums and to enhance its risk-adjusted returns.

Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.